A Prospective Observational Study of the Correlation between Hormone Receptor Status and Other Prognostic Factors in Carcinoma Breast in a Rural Set Up in Central India

Raju Gore¹, Tanweerul Huda² and Bharati Pandya^3,

¹Department of General Surgery, Mahatma Gandhi Institute of Medical Sciences, Sevagram, India

²Department of General Surgery, L N Medical College, Bhopal, India

³Department of General Surgery, All India Institute of Medical Sciences, Bhopal, India

Cite this paper:
Raju Gore, Tanweerul Huda and Bharati Pandya. A Prospective Observational Study of the Correlation between Hormone Receptor Status and Other Prognostic Factors in Carcinoma Breast in a Rural Set Up in Central India. Journal of Cancer Research and Treatment. 2020; 8(2):15-20. doi: 10.12691/jcrt-8-2-2

Abstract

Breast cancer is a major concern in modern India. The growing population of the patients and the increased death toll require immediate attention from the scientific and medical community. Patients¡¯ age, socio-economic condition, and disease awareness play vital roles in the disease onset and progression. In this study, we have conducted a rigorous survey between 2012 and 2014 and investigated all possible contexts in relevance to the disease. From socio-economic to clinical and histopathological relevance were explored. Detail analysis was done for 112 patients. Our data shows Indian scenario having differences not only in stage at presentation with poorer survival but also that the age at presentation is almost a decade earlier than western studies. Only 8% of the participant patients were found to be nulliparous. Very few patients (11.60%) were found to be linked with the disease hereditarily. Statistical co-relation was found between ER status, PR status, lymph nodes, and age of the patients. Our study has shown similarity with the earlier studies as well as dissimilarity in certain facts. We expect this study will increase the present understanding of breast cancer in India.

Keywords:
breast cancer hormone receptor rural study staging and grading

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	J. L. Kelsey and L. Bernstein, "Epidemiology and prevention of breast cancer," Annual Review of Public Health, vol. 17, no. 1, pp. 47-67, 1996.
[2]	T. J. Key, P. K. Verkasalo and E. Banks, "Epidemiology of breast cancer," The Lancet Oncology, vol. 2, no. 3, pp. 133-140, 2001.
[3]	G. A. Colditz, "Epidemiology and prevention of breast cancer," Cancer Epidemiology and Prevention Biomarkers, vol. 14, no. 4, pp. 768-772, 2005.
[4]	B. W. K. P. Stewart and C. P. Wild, "World cancer report 2014," 2004.
[5]	F. Bray, J. Ferlay, I. Soerjomataram, R. L. Siegel, L. A. Torre and A. Jemal, "Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries," CA:A Cancer Journal for Clinicians, vo. 68, no. 6, pp. 394-424, 2018.
[6]	Y. M. Martei, L. E. Pace, J. E. Brock and L.N. Shulman, "Breast cancer in low-and middle-income countries: Why we need pathology capability to solve this challenge," Clinics in Laboratory Medicine, vol. 38, no. 1, pp. 161-173, 2018.
[7]	J. H. Park, S. K. Lee, J. E. Lee et al., "Breast cancer epidemiology of the working-Age female population reveals significant implications for the south korean economy," Journal of Breast Cancer, vol. 21, no. 1, pp. 91-95, 2018.
[8]	S. Malvia, S. A. Bagadi, U. S. Dubey and S. Saxena, "Epidemiology of breast cancer in Indian women," Asia-Pacific Journal of Clinical Oncology, vol. 13, no. 4, pp. 289-295, 2017.
[9]	M. C. Pike, "Age-related factors in cancers of the breast, ovary, and endometrium," Journal of Chronic Diseases, vol. 40, pp. 59S-69S, 1987.
[10]	D. E. Starreveld, S. E. Markovitz, G. van Breukelen and M. L. Peters, "The course of fear of cancer recurrence: Different patterns by age in breast cancer survivors," Psycho-oncology, vol. 27, no. 1, pp. 295-301, 2018.
[11]	L. Wu, W. Shi, J. Long et al., "A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer," Nature Genetics, vol. 50, no. 7, pp. 968, 2018.
[12]	S. J. Kim, A. E. Glassgow, K. S. Watson, Y. Molina and E. A. Calhoun, "Gendered and racialized social expectations, barriers, and delayed breast cancer diagnosis," Cancer, vol. 124, no. 22, pp. 4350-4357, 2018.
[13]	A. E. Heitz, R. N. Baumgartner, K. B. Baumgartner and S. D. Boone, "Healthy lifestyle impact on breast cancer-specific and all-cause mortality,' Breast Cancer Research and Treatment, vol. 167, no. 1, pp. 171-181, 2018.
[14]	A. Khodadadi-Jamayran, B. Akgol-Oksuz, Y. Afanasyeva et al., "Prognostic role of elevated mir-24-3p in breast cancer and its association with the metastatic process," Oncotarget, vol. 9, no. 16, pp. 12868, 2018.
[15]	Y. Asano, S. Kashiwagi, W. Goto et al., "Expression and clinical significance of androgen receptor in triple-negative breast cancer," Cancers (Basel), vol. 9, no. 1, pp. 4, 2017.
[16]	O. L. Griffith, N. C. Spies, M. Anurag et al., "The prognostic effects of somatic mutations in ER-positive breast cancer," Nature Communications, vol. 9, no. 1, pp. 3476, 2018.
[17]	D. M. Parkin and C. S. Muir, "Cancer incidence in five continents," IARC Scientific Publications, 120, pp. 45-173, 1992.
[18]	S. S. Amr, A. R. Sa'di, F. Ilahi and S. S. Sheikh, "The spectrum of breast diseases in Saudi Arab females: a 26-year pathological survey at Dhahran Health Center," Annals Saudi Medicine, vol. 15, no. 2, pp. 125-132, 1995.
[19]	K. McPherson, C. Steel and J. M. Dixon, "ABC of breast diseases: breast cancer¡ªepidemiology, risk factors, and genetics," BMJ: British Medical Journal, vol. 321, no. 7261, pp. 624, 2000.
[20]	D. S. Sandhu, S. Sandhu, R. K. Karwasra and S. Marwah, "Profile of breast cancer patients at a tertiary care hospital in north India," Indian Journal of Cancer, vol. 47, no. 1, pp. 16-22, 2010.
[21]	P. Parameshwari, K. Muthukumar and J. H. Gladius, "A Population Based Case Control Study on Breast Cancer and the Associated Risk Factors in a Rural Setting in Kerala, Southern India," Journal of Clinical Diagnosis and Research, vol. 7, no. 9, pp. 1913-1916, 2013.
[22]	D. Apter and R. Vihko, "Early menarche, a risk factor for breast cancer, indicates early onset of ovulatory cycles," The Journal of Clinical Endocrinology & Metabolism, vol. 57, no. 1, pp. 82-86, 1983.
[23]	J. H. Hendriks, J. D. Otten, R. Holland and A. L. Verbeek, "Parity and mammographic breast density in relation to breast cancer risk: indication of interaction," European Journal of Cancer Prevention. vol. 9, no. 2, pp. 105-111, 2000.
[24]	R. S. Lodha, S. Nandeshwar, D. K. Pal et al., "Risk factors for breast cancer among women in Bhopal urban agglomerate: a case-control study," Asian Pacific Journal of Cancer Prevention, vol. 12, no. 8, pp. 2111-5, 2011.
[25]	B. MacMahon, P. Cole, T. M. Lin et al., "Age at first birth and breast cancer risk," Bulletin of the World Health Organization, vol. 43, no. 2, pp. 209, 1970.
[26]	T. J. Key, P. K. Verkasalo and E. Banks, "Epidemiology of breast cancer," The Lancet Oncology, vol. 2, no. 3, pp. 133-140, 2001.
[27]	V. Gajalakshmi, A. Mathew, P. Brennan et al., "Breastfeeding and breast cancer risk in India: A multicenter case-control study," International Journal of Cancer, vol. 125, no. 3, pp. 662-665, 2009.
[28]	Y. Zhou, J. Chen, Q. Li, W. Huang, H. Lan and H. Jiang, "Association between breastfeeding and breast cancer risk: evidence from a meta-analysis," Breastfeeding Medicine, vol. 10, no. 3, pp. 175-182, 2015.
[29]	S. Colonna, K. Curtin, E. Johnson et al., "Family History of Breast Cancer Associated with Breast Cancer in Survivors of Hodgkin Lymphoma," International Journal of Cancer and Clinical Research, vol. 6, no. 1, pp. 107, 2019.
[30]	C. Burgess, M. S. Hunter and A. J. Ramirez, "A qualitative study of delay among women reporting symptoms of breast cancer," British Journal of General Practice, vol. 51, no. 473, pp. 967-971, 2001.
[31]	T. Richards, A. Hunt, S. Courtney and H. Umeh, "Nipple discharge: a sign of breast cancer?," The Annals of The Royal College of Surgeons of England, vol. 89, no. 2, pp. 124-126, 2007.
[32]	T. Busk, and J. Clemmesen, "The frequencies of left-and right-sided breast cancer," British Journal of Cancer, vol. 1, no. 4, pp. 345, 1947.
[33]	L. Garfinkel, L. Craig and H. Seidman, "An appraisal of left and right breast cancer," Journal of the National Cancer Institute, vol. 23, no. 4, pp. 617-631, 1959.
[34]	C. L. Carter, C. Allen and D. E. Henson, "Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases," Cancer, vol. 63, no. 1, pp. 181-187, 1989.
[35]	U. Veronesi, A. Luini, V. Galimberti, S. Marchini, V. Sacchini and F. Rilke, "Extent of metastatic axillary involvement in 1446 cases of breast cancer," European Journal of Surgical Oncology, vol. 16, no. 2, pp. 127-133, 1990.
[36]	B. Chua, O. Ung, R. Taylor, J. Boyages, "Frequency and predictors of axillary lymph node metastases in invasive breast cancer," ANZ Journal of Surgery, vol. 71, no. 12, pp. 723-728, 2001.
[37]	R. S. Boova, R. Bonanni, F. E. Rosato, "Patterns of axillary nodal involvement in breast cancer. Predictability of level one dissection," Annals of Surgery, vol. 196, no. 6, pp. 642, 1982.
[38]	T. Fukui, S. Mori, K. Yokoi and T. Mitsudomi, "Significance of the number of positive lymph nodes in resected non-small cell lung cancer," Journal of Thoracic Oncology, vol. 1, no. 2, pp. 120-125, 2006.
[39]	J. Yang, Q. Long, H. Li, Q. Lv, Q. Tan and X. Yang, "The value of positive lymph nodes ratio combined with negative lymph node count in prediction of breast cancer survival," Journal of Thoracic Disease, vol. 9, no. 6, pp. 1531, 2017.
[40]	J. Y. Kim, M. R. Ryu, B. O. Choi et al., "The prognostic significance of the lymph node ratio in axillary lymph node positive breast cancer," Journal of Breast Cancer, vol. 14, no. 3, pp. 204-212, 2011.
[41]	S. Gruvberger, M. Ringn¨¦r, Y. Chen et al., "Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns," Cancer Research, vol. 61, no. 16, pp. 5979-5984, 2001.
[42]	W. Y. Huang, B. Newman, R. C. Millikan, M. J. Schell, B. S. Hulka and P. G. Moorman, "Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status," American Journal of Epidemiology, vol. 151, no. 7, pp. 703-714, 2000.
[43]	F. F. Parl, B. P. Schmidt, W. D. Dupont and R. K. Wagner, "Prognostic significance of estrogen receptor status in breast cancer in relation to tumor stage, axillary node metastasis, and histopathologic grading," Cancer, vol. 54, no. 10, pp. 2237-2242, 1984.